These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 18692537
1. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW. Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537 [Abstract] [Full Text] [Related]
2. Preclinical testing of a vaccine candidate against tularemia. Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M, Bakshi CS. PLoS One; 2015 Sep 26; 10(4):e0124326. PubMed ID: 25897786 [Abstract] [Full Text] [Related]
3. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Baron SD, Singh R, Metzger DW. Infect Immun; 2007 May 26; 75(5):2152-62. PubMed ID: 17296747 [Abstract] [Full Text] [Related]
4. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice. Sunagar R, Kumar S, Franz BJ, Gosselin EJ. Vaccine; 2016 Jun 17; 34(29):3396-404. PubMed ID: 27182819 [Abstract] [Full Text] [Related]
5. Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing. Sunagar R, Kumar S, Namjoshi P, Rosa SJ, Hazlett KRO, Gosselin EJ. PLoS One; 2018 Jun 17; 13(12):e0207587. PubMed ID: 30533047 [Abstract] [Full Text] [Related]
12. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Bar-On L, Cohen H, Elia U, Rotem S, Bercovich-Kinori A, Bar-Haim E, Chitlaru T, Cohen O. Vaccine; 2017 Dec 15; 35(50):7001-7009. PubMed ID: 29102170 [Abstract] [Full Text] [Related]
14. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW. Infect Immun; 2013 Sep 15; 81(9):3099-105. PubMed ID: 23774604 [Abstract] [Full Text] [Related]
15. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain. Sanapala S, Yu JJ, Murthy AK, Li W, Guentzel MN, Chambers JP, Klose KE, Arulanandam BP. Infect Immun; 2012 Jun 15; 80(6):2177-85. PubMed ID: 22493083 [Abstract] [Full Text] [Related]
16. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS). De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL. mBio; 2014 Apr 08; 5(2):e00936. PubMed ID: 24713322 [Abstract] [Full Text] [Related]
17. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Anderson RV, Crane DD, Bosio CM. Vaccine; 2010 Sep 14; 28(40):6562-72. PubMed ID: 20688042 [Abstract] [Full Text] [Related]
18. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model. Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S. Microbiol Immunol; 2018 Jan 14; 62(1):24-33. PubMed ID: 29171073 [Abstract] [Full Text] [Related]